Company: CERO
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001213900-25-073849
Chunk: 25

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-11
Form: S-3
Chunk 25
---
 |

| ● | an exchange distribution in accordance with the rules of the applicable exchange; |

| ● | privately negotiated transactions; |

| ● | short sales made after the date the Registration Statement is declared effective by the SEC; |

| ● | broker-dealers may agree with a selling security holder to sell a specified number of such shares at a 
 stipulated price per share;                                                                            |

| ● | a combination of any such methods of sale; and |

| ● | any other method permitted pursuant to applicable law. |

The Selling Stockholders may also sell shares
of common stock under Rule 144 promulgated under the Securities Act of 1933, as amended, if available, rather than under this prospectus.
In addition, the Selling Stockholders may transfer the shares of common stock by other means not described in this prospectus. If the
Selling Stockholders effect such transactions by selling shares of common stock to or through underwriters, broker-dealers or agents,
such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the Selling
Stockholders or commissions from purchasers of the shares of common stock for whom they may act as agent or to whom they may sell as principal
(which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary
in the types of transactions involved). In connection with sales of the shares of common stock or otherwise, the Selling Stockholders
may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of common stock in the
course of hedging in positions they assume. The Selling Stockholders may also sell shares of common stock short and deliver shares of
common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales.
The Selling Stockholders may also loan or pledge shares of common stock to broker-dealers that in turn may sell such shares.

<div align='center'>11</div>

The Selling Stockholders may pledge or grant a
security interest in some or all of the Series D Preferred Stock or shares of common stock owned by them and, if they default in the performance
of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time pursuant
to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending,
if necessary, the